LDL-lowering therapy and the risk of prostate cancer: a meta-analysis of 6 randomized controlled trials and 36 observational studies
Author:
Publisher
Springer Science and Business Media LLC
Subject
Multidisciplinary
Link
http://www.nature.com/articles/srep24521.pdf
Reference57 articles.
1. Siegel, R., Ma, J., Zou, Z. & Jemal, A. Cancer statistics. CA-Cancer J. Clin. 64, 9–29 (2014).
2. Carlberg, M. et al. Mevalonic acid is limiting for N-linked glycosylation and translocation of the insulin-like growth factor-1 receptor to the cell surface. Evidence for a new link between 3-hydroxy-3-methylglutaryl-coenzyme a reductase and cell growth. J. Biol. Chem. 271, 17453–17462 (1996).
3. Wong, W. W., Dimitroulakos, J., Minden, M. D. & Penn, L. Z. HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis. Leukemia 16, 508–519, 10.1038/sj.leu.2402476 (2002).
4. Jain, M. K. & Ridker, P. M. Anti-inflammatory effects of statins: clinical evidence and basic mechanisms. Nat. Rev. Drug. Discov. 4, 977–987 (2005).
5. Dulak, J. & Jozkowicz, A. Anti-angiogenic and anti-inflammatory effects of statins: relevance to anti-cancer therapy. Curr. Cancer Drug Tar. 5, 579–594 (2005).
Cited by 30 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Effect of statins and testosterone replacement therapy on incident cardiovascular disease among male hormone-related cancer survivors;2023-11-03
2. Association Between Statin Exposure and Incidence and Prognosis of Prostate Cancer;American Journal of Clinical Oncology;2023-05-05
3. Association between genetically proxied PCSK9 inhibition and prostate cancer risk: A Mendelian randomisation study;PLOS Medicine;2023-01-03
4. Statin use and risk of cancer: An umbrella meta-analysis;Annals of Oncology Research and Therapy;2023
5. Statin Use and Survival Among Men Receiving Androgen-Ablative Therapies for Advanced Prostate Cancer;JAMA Network Open;2022-11-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3